Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userDynamical characterization of combinatorially rich sets near zero
60
0
0.0
(
0
)
Authors
Sourav Kanti Patra
Ask ChatGPT about the research
No Arabic abstract
Hindman and Leader first introduced the notion of Central sets near zero for dense subsemigroups of $((0,infty),+)$ and proved a powerful combinatorial theorem about such sets. Using the algebraic structure of the Stone-$breve{C}$ech compactification, Bayatmanesh and Tootkabani generalized and extended this combinatorial theorem to the central theorem near zero. Algebraically one can define quasi-central set near zero for dense subsemigroup of $((0,infty),+)$, and they also satisfy the conclusion of central sets theorem near zero. In a dense subsemigroup of $((0,infty),+)$, C-sets near zero are the sets, which satisfies the conclusions of the central sets theorem near zero. Like discrete case, we shall produce dynamical characterizations of these combinatorically rich sets near zero.
rate research
Read More
Assume M is a 3-dimensional real manifold without boundary, A is an abelian Lie algebra of analytic vector fields on M, and X is an element of A. The following result is proved: If K is a locally maximal compact set of zeroes of X and the Poincare-Hopf index of X at K is nonzero, there is a point in K at which all the elements of A vanish.
By an emph{assignment} we mean a mapping from a Choquet simplex $K$ to probability measure-preserving systems, obeying some natural restrictions. We prove that if $Phi$ is an aperiodic assignment on a Choquet simplex $K$ such that the set of extreme points $mathsf{ex}K$ is a countable union $bigcup_n E_n$, where each set $E_n$ is compact, zero-dimensional, and the restriction of $Phi$ to the Bauer simplex $K_n$ spanned by $E_n$ can be `embedded in some topological dynamical system, then $Phi$ can be `realized in a zero-dimensional system.
A subset $D$ of an Abelian group is $decomposable$ if $emptyset e Dsubset D+D$. In the paper we give partial answer to an open problem asking whether every finite decomposable subset $D$ of an Abelian group contains a non-empty subset $Zsubset D$ with $sum Z=0$. For every $ninmathbb N$ we present a decomposable subset $D$ of cardinality $|D|=n$ in the cyclic group of order $2^n-1$ such that $sum D=0$, but $sum T e 0$ for any proper non-empty subset $Tsubset D$. On the other hand, we prove that every decomposable subset $Dsubsetmathbb R$ of cardinality $|D|le 7$ contains a non-empty subset $Zsubset D$ of cardinality $|Z|lefrac12|D|$ with $sum Z=0$. For every $ninmathbb N$ we present a subset $Dsubsetmathbb Z$ of cardinality $|D|=2n$ such that $sum Z=0$ for some subset $Zsubset D$ of cardinality $|Z|=n$ and $sum T e 0$ for any non-empty subset $Tsubset D$ of cardinality $|T|<n=frac12|D|$. Also we prove that every finite decomposable subset $D$ of an Abelian group contains two non-empty subsets $A,B$ such that $sum A+sum B=0$.
Let $(X,mathscr{B}, mu,T,d)$ be a measure-preserving dynamical system with exponentially mixing property, and let $mu$ be an Ahlfors $s$-regular probability measure. The dynamical covering problem concerns the set $E(x)$ of points which are covered by the orbits of $xin X$ infinitely many times. We prove that the Hausdorff dimension of the intersection of $E(x)$ and any regular fractal $G$ equals $dim_{rm H}G+alpha-s$, where $alpha=dim_{rm H}E(x)$ $mu$--a.e. Moreover, we obtain the packing dimension of $E(x)cap G$ and an estimate for $dim_{rm H}(E(x)cap G)$ for any analytic set $G$.
Mathematical models describing SARS-CoV-2 dynamics and the corresponding immune responses in patients with COVID-19 can be critical to evaluate possible clinical outcomes of antiviral treatments. In this work, based on the concept of virus spreadability in the host, antiviral effectiveness thresholds are determined to establish whether or not a treatment will be able to clear the infection. In addition, the virus dynamic in the host -- including the time-to-peak and the final monotonically decreasing behavior -- is chracterized as a function of the treatment initial time. Simulation results, based on nine real patient data, show the potential clinical benefits of a treatment classification according to patient critical parameters. This study is aimed at paving the way for the different antivirals being developed to tackle SARS-CoV-2.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
